Suchergebnisse - "Yang, Nong"

PubPharm (185)

1

A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China : A multicenter, cross-sectional study

enthalten in: Cancer | 2024

von Chen, M. | Li, L. | Xia, Q. | +37

2

First-in-human phase I study of BEBT-109 in previously treated EGFR exon 20 insertion-mutated advanced non-small cell lung cancer

enthalten in: Med (New York, N.Y.) | 2024

von Zeng, L. | Song, L. | Liu, L. | +18

3

Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor : results from three cancer centers in China

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Yan, H. | Song, L. | Li, Y. | +23

4

Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312) : A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Cheng, Y. | Fan, Y. | Zhao, Y. | +16

5

Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China

enthalten in: Cancer immunology immunotherapy | 2024

von Yan, H. | Song, L. | Li, Y. | +23

6

Intracranial response pattern, tolerability and biomarkers associated with brain metastases in non-small cell lung cancer treated by tislelizumab plus chemotherapy

enthalten in: Translational lung cancer research | 2024

von Zhao, S. | Jiang, W. | Yang, N. | +9

7

First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302) : a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial

enthalten in: The Lancet. Respiratory medicine | 2024

von Zhong, H. | Sun, S. | Chen, J. | +41

8

Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer : The Neotorch Randomized Clinical Trial

enthalten in: JAMA | 2024

von Lu, S. | Zhang, W. | Wu, L. | +63

9

Lipid alterations play a role in the integration of PD-1/PD-L1 inhibitors and anlotinib for the treatment of advanced non-small-cell lung cancer

enthalten in: Lipids in health and disease | 2024

von Liu, L. | Zhang, S. | Yang, H. | +4

10

Lipid alterations play a role in the integration of PD-1/PD-L1 inhibitors and anlotinib for the treatment of advanced non–small-cell lung cancer

enthalten in: Lipids in health and disease | 2024

von Liu, L. | Zhang, S. | Yang, H. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]